Marbeta 25 Kit (Page 12 of 12)

Inactive Ingredients

Inactive ingredients: Citric acid, glycerin, polysorbate 80, sodium citrate USP, sodium phosphate dibasic, water

Isopropyl Alcohol 70% Prep Pads

Active ingredient

Isopropyl Alcohol 70% v/v

Purpose

Antiseptic

Uses

For first aid to decrease germs in

  • minor cuts
  • scrapes
  • burns

For preparation of the skin prior to injection

Warnings

For external use only

Flammable — keep away from fire or flame

Do not use

with electrocautery procedures

When using this product do not

  • get into eyes
  • apply over large areas of the body
  • in case of deep or puncture wounds, animal bites or serious burns consult a doctor

Stop use and ask a doctor if

  • condition persists or gets worse or lasts for more than 72 hours
  • do not use longer than 1 week unless directed by a doctor

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

  • apply to skin as needed
  • discard after single use

Other information

Protect from freezing and avoid excessive heat

Inactive ingredient

Water

PRINCIPAL DISPLAY PANEL

NDC: 76420-785-01

Rx Only

Marbeta-25â„¢

Kit Contains

1 Bupivacaine HCl 0.25% Single Dose Vial (10mL)

1 Betamethasone Sodium Phosphate and Betamethasone Acetate 6mg/mL (5mL)

1 Povidone-Iodine Swabsticks (3 Swabs)

3 Isopropyl Alcohol 70% Prep Pads

1 Pair Nitrile Powder Free Sterile Gloves (M)

1 Drape

1 Adhesive Bandage

5 Non Sterile 4×4 Gauze

Needles and Syringes Not Included

1 Dose

Single Use Only

Distributed by:

Enovachemâ„¢

PHARMACEUTICALS

Torrance, CA 90501

Principal Display Panel
(click image for full-size original)
MARBETA 25 KIT betamethasone sodium phosphate and betamethasone acetate, bupivacaine hydrochloride, povidine iodine kit
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:76420-785
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:76420-785-01 1 KIT in 1 CARTON None
Quantity of Parts
Part # Package Quantity Total Product Quantity
Part 1 1 VIAL, MULTI-DOSE 5 mL
Part 2 1 VIAL, SINGLE-DOSE 10 mL
Part 3 1 PACKET 0.9 mL
Part 4 3 POUCH 15 mL
Part 1 of 4
BETAMETHASONE SODIUM PHOSPHATE AND BETAMETHASONE ACETATE betamethasone sodium phosphate and betamethasone acetate injection, suspension
Product Information
Item Code (Source) NDC:0517-0720
Route of Administration INTRA-ARTICULAR, INTRAMUSCULAR, INTRALESIONAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
BETAMETHASONE SODIUM PHOSPHATE (BETAMETHASONE) BETAMETHASONE 3 mg in 1 mL
BETAMETHASONE ACETATE (BETAMETHASONE) BETAMETHASONE ACETATE 3 mg in 1 mL
Inactive Ingredients
Ingredient Name Strength
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS 7.1 mg in 1 mL
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE 3.4 mg in 1 mL
EDETATE DISODIUM 0.1 mg in 1 mL
BENZALKONIUM CHLORIDE 0.2 mg in 1 mL
WATER
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0517-0720-01 1 VIAL, MULTI-DOSE in 1 CARTON contains a VIAL, MULTI-DOSE
1 5 mL in 1 VIAL, MULTI-DOSE This package is contained within the CARTON (0517-0720-01)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA090747 04/28/2010
Part 2 of 4
BUPIVACAINE HYDROCHLORIDE bupivacaine hydrochloride injection, solution
Product Information
Item Code (Source) NDC:0143-9330
Route of Administration EPIDURAL, INFILTRATION DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
BUPIVACAINE HYDROCHLORIDE (BUPIVACAINE) BUPIVACAINE HYDROCHLORIDE ANHYDROUS 2.5 mg in 1 mL
Inactive Ingredients
Ingredient Name Strength
SODIUM CHLORIDE
SODIUM HYDROXIDE
HYDROCHLORIC ACID
WATER
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0143-9330-10 10 VIAL, SINGLE-DOSE in 1 CARTON contains a VIAL, SINGLE-DOSE (0143-9330-01)
1 NDC:0143-9330-01 10 mL in 1 VIAL, SINGLE-DOSE This package is contained within the CARTON (0143-9330-10)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA204842 02/11/2021
Part 3 of 4
POVIDINE IODINE povidine iodine swab
Product Information
Item Code (Source) NDC:67777-419
Route of Administration TOPICAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
POVIDONE-IODINE (IODINE) IODINE 10 mg in 1 mL
Inactive Ingredients
Ingredient Name Strength
GLYCERIN
POLYSORBATE 80
SODIUM CITRATE
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
CITRIC ACID ACETATE
WATER
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:67777-419-02 0.9 mL in 1 PACKET None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
OTC monograph final part333C 09/13/2016
Part 4 of 4
ISOPROPYL ALCOHOL isopropyl alcohol swab
Product Information
Route of Administration TOPICAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
ISOPROPYL ALCOHOL (ISOPROPYL ALCOHOL) ISOPROPYL ALCOHOL 70 mL in 100 mL
Inactive Ingredients
Ingredient Name Strength
WATER
Packaging
# Item Code Package Description Multilevel Packaging
1 5 mL in 1 POUCH None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
OTC monograph not final part333A 01/01/2007
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
unapproved drug other 04/28/2010
Labeler — Asclemed USA, Inc. (059888437)

Revised: 07/2022 Asclemed USA, Inc.

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2022. All Rights Reserved.